Why the study?
Does single-stage multivessel percutaneous coronary intervention improve outcomes compared to culprit vessel-only percutaneous coronary intervention in patients with cardiogenic shock complicating ST-segment-elevation myocardial infarction?
Does single-stage multivessel percutaneous coronary intervention improve outcomes compared to culprit vessel-only percutaneous coronary intervention in patients with cardiogenic shock complicating ST-segment-elevation myocardial infarction?
Answers are grounded in this paper and cite their sources.
In patients with cardiogenic shock complicating STEMI, observational data suggests no significant benefit of single-stage multivessel PCI over culprit-only PCI, highlighting the need for randomized trials.
This meta-analysis of nonrandomized studies suggests that in patients with cardiogenic shock complicating ST-segment-elevation myocardial infarction, there may be no significant benefit with single-stage MV-PCI compared with CO-PCI. Given the limitations of observational data, randomized trials are needed to determine the role of MV-PCI in this setting.
No takes yet. Share an insight, caveat, or question.
Kolte et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: